American Medical Society for Sports Medicine (AMSSM)

AMSSM Awards $300K Research Grant to Study Cardiac Outcomes in Athletes, Including Those Affected by COVID-19

Newswise — The AMSSM Collaborative Research Network (CRN) is pleased to announce the recipients of the 2020 AMSSM CRN $300K Research Grant. Drs. Jonathan Drezner, Kimberly Harmon and Aaron Baggish will serve as co-principal investigators for their research project titled "Outcomes Registry for Cardiac Conditions in Athletes (the ORCCA Study): a Prospective, Multisite Research Study."

The long-term objective of their project is to establish an outcomes registry for competitive athletes diagnosed with cardiovascular disease. Initially, the investigators will launch a national registry using a cohort of NCAA athletes afflicted with COVID-19 to address urgent clinical questions related to the impact of SARS-CoV-2 on cardiovascular pathology and the risk of myocardial injury. Specifically, the group will examine the diagnostic yield of pre-participation cardiac testing and the prevalence of myocarditis or adverse cardiovascular events among NCAA athletes with COVID-19 infections. They will then expand the focus of this registry to capture the clinical implications and outcomes of traditional (i.e. non-COVID-related genetic and congenital) forms of cardiovascular pathology.

"We are honored to receive this research grant to establish a national outcomes registry for athletes with cardiac conditions," Dr. Drezner said. "We hope to develop an evidence base that will inform management decisions and safe exercise recommendations for young athletes with cardiovascular pathology."

The study team consists of AMSSM clinicians and researchers at various locations, including the University of Washington-Seattle (Drs. Drezner and Harmon) and Harvard University (Dr. Baggish). Approximately 70 NCAA universities with Division I athletic programs and historically black colleges and universities associated with the Central Intercollegiate Athletic Conference (CIAA) have agreed to participate in the registry. Numerous AMSSM member team physicians at these institutions will help form the network to contribute data for this registry.

According to Dr. Harmon, "The response from team physicians and athletic trainers in support of this project has been nothing short of amazing. This project truly demonstrates the generosity and the collegiality among peers that AMSSM helps to foster."    

Concerns for myocarditis have prompted widespread modifications to pre-participation cardiovascular screening in athletes afflicted with COVID-19, including the addition of specific testing designed to increase detection of myocarditis such as echocardiography, cardiac biomarkers, and cardiac magnetic resonance imaging. While several expert consensus guidelines for the cardiac evaluation of athletes after COVID-19 infection have been developed, limited data is available to guide an evidence-based screening strategy. This registry will seek to provide critical evidence to inform decisions about the health and safety of competitive athletes during the COVID-19 pandemic and beyond.

Dr. Drezner added, "The extent to which mild or asymptomatic COVID-19 infections affect the heart is unknown. This study will provide important data to guide clinical investigations and a safe return to sports during the COVID-19 pandemic."  

The team of investigators will work closely with the CRN Leadership Committee on this project over the next two years and beyond. The CRN looks forward to partnering with these investigators to share results with the membership as they become available.

"The CRN is excited to support this talented group of researchers in the quest for answers to short and long-term questions around cardiac complications and exercise," said Dr. Anthony Beutler, Chair of the CRN. "The prominence of this registry highlights the world-wide leadership role of AMSSM in sport and the outstanding work that AMSSM members perform daily to improve the health of athletes everywhere."

This $300,000 grant award is being equally funded by AMSSM and the AMSSM Foundation as part of a $1 million-plus, five-year plan to support competitive CRN research awards.

About the AMSSM: AMSSM is a multi-disciplinary organization of sports medicine physicians dedicated to education, research, advocacy and the care of athletes of all ages. The majority of AMSSM members are primary care physicians with fellowship training and added qualification in sports medicine who then combine their practice of sports medicine with their primary specialty. AMSSM includes members who specialize solely in non-surgical sports medicine and serve as team physicians at the youth level, NCAA, NFL, MLB, NBA, WNBA, MLS and NHL, as well as with Olympic and Paralympic teams. By nature of their training and experience, sports medicine physicians are ideally suited to provide comprehensive medical care for athletes, sports teams or active individuals who are simply looking to maintain a healthy lifestyle. www.amssm.org




Filters close

Showing results

110 of 4578
Newswise: UCLA Researcher’s Team Finds Common Blood Pressure Medications do not Increase COVID-19 Risk
Released: 18-Jan-2021 12:05 PM EST
UCLA Researcher’s Team Finds Common Blood Pressure Medications do not Increase COVID-19 Risk
UCLA Fielding School of Public Health

Dr. Marc Suchard, of the UCLA Fielding School of Public Health, co-led international research team looking at two widely used types of blood pressure drugs.

Newswise: UCLA Fielding School of Public Health Researchers Say Mask Mandates Could add $1 Trillion to the U.S. GDP
Released: 18-Jan-2021 12:05 PM EST
UCLA Fielding School of Public Health Researchers Say Mask Mandates Could add $1 Trillion to the U.S. GDP
UCLA Fielding School of Public Health

The team, including UCLA Fielding School of Public Health professors Anne Rimoin and Christina Ramirez, found that near-universal adoption of nonmedical masks in public, combined with complementary public health measures, could successfully eliminate spread of the infection. and add $1 Trillion to the U.S. GDP.

Released: 18-Jan-2021 10:45 AM EST
Mount Sinai Researchers Build Models Using Machine Learning Technique to Enhance Predictions of COVID-19 Outcomes
Mount Sinai Health System

Mount Sinai researchers have published one of the first studies using federated learning to examine electronic health records to better predict how COVID-19 patients will progress.

Newswise:Video Embedded pregnant-women-should-consider-taking-the-covid-19-vaccine
VIDEO
Released: 18-Jan-2021 7:50 AM EST
Pregnant women should consider taking the COVID-19 vaccine.
University of Washington School of Medicine

f pregnant individuals catch COVID they will generally get sicker than non-pregnant individuals. They also more commonly end up on ECMO [heart-lung support], in the ICU or on ventilators.

Newswise: Have allergies? Worried about COVID-19 vaccine? Don’t be.
Released: 18-Jan-2021 7:40 AM EST
Have allergies? Worried about COVID-19 vaccine? Don’t be.
UW Medicine

Even people who have experienced severe allergic reactions to food, latex, pets, pollen, or bee stings should get the coronavirus vaccine, UW Medicine allergy and infectious disease experts say.

Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.


Showing results

110 of 4578

close
1.70061